Laboratorios Echevarne, S.A. (manufacturer responsible for control of sterile products)

The drug is prescribed as monotherapy for the treatment of locally advanced or metastatic estrogen receptor-positive breast cancer in postmenopausal women. It is also used in combination with palbociclib for the treatment of appropriate breast cancer in women who have previously received endocrine therapy.

Dosage form: solution for injection

ATC: L02BA03